Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes-Reference-Cited by-同舟云学术

Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes

Published:2017-03 Issue: Volume:4 Page:50-61
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Svendsen Pia,Graversen Jonas H.,Etzerodt Anders,Hager Henrik,Røge Rasmus,Grønbæk Henning,Christensen Erik I.,Møller Holger J.,Vilstrup Hendrik,Moestrup Søren K.

Funder

European Research Council

TROJA program advanced grant

NASH program PoC grant

Novo Nordisk Foundation

Danish Medical Research Council

Danish Strategic Council

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference62 articles.

1. The intersection of nonalcoholic fatty liver disease and obesity;Woo Baidal;Sci. Trans. Med.,2016

2. Role of diet and nutritional management in non-alcoholic fatty liver disease;Fan;J. Gastroenterol. Hepatol.,2013

3. Soft drink consumption and obesity: it is all about fructose;Bray;Curr. Opin. Lipidol.,2010

4. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop;Sanyal;Hepatology,2015

5. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics;Livers;2024-09-13

2. YAP activation in liver macrophages via depletion of MST1/MST2 enhances liver inflammation and fibrosis in MASLD;The FASEB Journal;2024-08-31

3. Glucocorticoids-based prodrug design: Current strategies and research progress;Asian Journal of Pharmaceutical Sciences;2024-06

4. The medicinal chemistry evolution of antibody–drug conjugates;RSC Medicinal Chemistry;2024

5. Targeted nanotheranostics for the treatment of epilepsy through in vivo hijacking of locally activated macrophages;Acta Biomaterialia;2024-01